Effect of a Probiotic Formula in Mild Cognitive Impairement

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

June 30, 2026

Conditions
Mild Cognitive Impairment (MCI)
Interventions
DIETARY_SUPPLEMENT

Probiotic Arm

Fifty of the participants will consume 1 capsule/day of the dietary supplement AB-MIND+CECT7481 for 16 weeks. The capsule should be taken just before breakfast. The researchers will instruct the volunteers to maintain their usual lifestyle (diet, physical activity, sleep habits) throughout the intervention period.

OTHER

Placebo

Fifty of the participants will consume 1 capsule/day of the PLACEBO for 16 weeks. The capsule should be taken just before breakfast. The researchers will instruct the volunteers to maintain their usual lifestyle (diet, physical activity, sleep habits) throughout the entire intervention period.

Trial Locations (2)

28040

Facultad de Farmacia Universidad Complutense de Madrid (UCM) Plaza Ramón y Cajal, Madrid

Hospital Clínico San Carlos, Madrid

All Listed Sponsors
collaborator

AB Biotics, SA

INDUSTRY

lead

Universidad Complutense de Madrid

OTHER

NCT06670807 - Effect of a Probiotic Formula in Mild Cognitive Impairement | Biotech Hunter | Biotech Hunter